Advanced Topics: Treating Your Patient with Novel Oral Anticoagulants

Thursday, December 6, 2012
2:00 PM – 4:00 PM

Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists; the ASHP Section of Ambulatory Care Practitioners; the ASHP Section of Inpatient Care Practitioners; the ASHP New Practitioners Forum; and the ASHP Pharmacy Student Forum
Activity #: 204-000-12-241-L01P
Level of Content: Advanced
2.00 Contact Hours / Application-based
Program Chair: Maureen Smythe, PharmD, FCCP

Learning Objectives:

• Compare and contrast dabigatran, rivaroxaban and apixaban therapy for stroke prevention in patients with atrial fibrillation.
  
• Discuss strategies for peri procedural management with the newer agents.
  
• Explain the impact of renal dysfunction of the safety and efficacy of the newer agents.
  
• Outline considerations for transitions of care and patient education.
  
• Discuss approaches to and limitations of laboratory monitoring with newer agents.